NRC expected to issue Mo-99 facility license for Shine in 2021

May 13, 2020, 9:10PMNuclear News

Shine Medical Technologies, which is building a medical isotope production facility in Janesville, Wis., said on May 11 that it expects to have an operating license issued by the Nuclear Regulatory Commission by October 2021. Shine’s application seeking approval to operate the facility, which will produce isotopes including molybdenum-99, was accepted and docketed by the NRC last October. Mo-99, the precursor to technetium-99m, is used in more than 40 million medical patient procedures every year.

To continue reading, log in or create a free account!

Related Articles

DOE, NRC prepare for government shutdown

October 1, 2025, 12:03PMNuclear News

The Department of Energy and the Nuclear Regulatory Commission will furlough thousands of employees and operate at reduced capacity under a government shutdown that started after midnight on...

Valar Atomics breaks ground in Utah

September 25, 2025, 9:30AMNuclear News

El Segundo, Calif.–based reactor start-up Valar Atomics recently announced that it has broken ground on its test reactor, the Ward 250, at Utah San Rafael Energy Lab (USREL), becoming the...

NRC’s hybrid AI workshop coming up

September 18, 2025, 7:21AMNuclear News

The Nuclear Regulatory Commission will host a hybrid public workshop on September 24 from 9 a.m. to 5 p.m. (EDT) to discuss its activities for the safe and secure use of artificial...